Co-morbidity but not dysglycaemia reduces quality of life in patients with type-2 diabetes treated with oral mono- or dual combination therapy -- an analysis of the DiaRegis registry
Conclusion:
The present study suggests, that co-morbidity but not average glycaemic control reduces health related quality of life in type 2 diabetes mellitus.
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Jürgen WasemPeter BramlageAnselm GittChristiane BinzMichael KreklerEvelin DeegDiethelm Tschöpe Source Type: research
More News: Cardiology | Cardiovascular | Depression | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Heart | Heart Failure | Hypertension | Neurology | Peripheral Neuropathy | Stroke | Study